Cancer Mechanisms

Search results

• Australia Patent for 'Compositions and methods for treating EZH2-mediated cancer' Ceases

  Parsons, R. & Jin, J.

  23/05/24

  1 item of Media coverage

  Press/Media

• Australia Patent: Application for 'Compositions and methods for treating EZH2-mediated cancer' Lapses

  Parsons, R. & Jin, J.

  23/05/24

  1 item of Media coverage

  Press/Media

• Is it time to reduce the length of postgraduate training for physician-scientists in internal medicine?

  Gallagher, E.

  22/05/24

  1 item of Media coverage

  Press/Media

• Tisch Cancer Institute Researcher Has Provided New Study Findings on Breast Cancer (Abstract PO5-02-01: Concerning Discrepancies in Estradiol Levels in Premenopausal Women Receiving Abemaciclib and Ovarian Function Suppression)

  Goel, A., Klein, P., Bhardwaj, A., Tiersten, A., Gallagher, E., Fasano, J. & Sparano, J.

  22/05/24

  1 item of Media coverage

  Press/Media

• Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

  Friedman, S.

  21/05/24

  1 item of Media coverage

  Press/Media

• Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

  Friedman, S.

  20/05/24

  1 item of Media coverage

  Press/Media

• Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

  Friedman, S.

  17/05/24

  1 item of Media coverage

  Press/Media

• US SECTOR DAILY: PRESS RELEASES OF LISTED COMPANIES IN THE BIOTECHNOLOGY SECTOR FRIDAY MAY 17, 2024

  Friedman, S.

  17/05/24

  1 item of Media coverage

  Press/Media

• Sagimet Biosciences To Host Virtual Investor And Analyst Day On Inhibiting Fatty Acid Synthase (FASN) To Reduce Liver Fat, Inflammation And Fibrosis In MASH On May 23, 2024

  Friedman, S.

  16/05/24

  1 item of Media coverage

  Press/Media

• Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024

  Friedman, S.

  16/05/24

  1 item of Media coverage

  Press/Media

• StreetEasy, Zillow join fight to reshape NYC broker fees

  Friedman, S.

  16/05/24

  1 item of Media coverage

  Press/Media

• Sagimet Biosciences To Host Virtual Investor And Analyst Day On Inhibiting Fatty Acid Synthase (FASN) To Reduce Liver Fat, Inflammation And Fibrosis In MASH On May 23, 2024

  Friedman, S.

  16/05/24

  78 items of Media coverage

  Press/Media

• StreetEasy, Zillow join fight to reshape NYC broker fees

  Friedman, S.

  16/05/24

  1 item of Media coverage

  Press/Media

• Researchers from Department of Neurology Publish New Studies and Findings in the Area of Streptococcus suis (Acute multiple brain infarctions associated with Streptococcus suis infection: a case report)

  Yu, Q.

  9/05/24

  1 item of Media coverage

  Press/Media

• Mediar Advances First-in-Class Fibrosis Portfolio to the Clinic with First Cohort Dosing in Phase 1 trial of MTX-463 & Establishes Clinical Advisory Board

  Friedman, S.

  9/05/24

  1 item of Media coverage

  Press/Media

• Mediar begins patient dosing in US FDA approved phase 1 trial of MTX-463

  Friedman, S.

  7/05/24

  2 items of Media coverage

  Press/Media

• Mediar begins patient dosing in US FDA approved phase 1 trial of MTX-463

  Friedman, S.

  6/05/24 → 7/05/24

  2 items of Media coverage

  Press/Media

• Data from Boston University Provide New Insights into Melanoma (The Corest Repressor Complex Mediates Phenotype Switching and Therapy Resistance In Melanoma)

  Fisher, R.

  6/05/24

  1 item of Media coverage

  Press/Media

• Mediar Advances First-in-Class Fibrosis Portfolio to the Clinic with First Cohort Dosing in Phase 1 trial of MTX-463 and Establishes Clinical Advisory Board

  Friedman, S.

  6/05/24

  77 items of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researcher Describes Findings in Prostate Cancer (Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer)

  Kyprianou, N. & Dogra, N.

  3/05/24

  1 item of Media coverage

  Press/Media

• Tongji University School of Medicine Reports Findings in Acne Vulgaris (Ionic Liquid Pretreatment Enhances Skin Penetration of 5-Aminolevulinic Acid: A Promising Scheme for Photodynamic Therapy for Acne Vulgaris)

  Yu, Q.

  30/04/24

  1 item of Media coverage

  Press/Media

• Leveraging Basic Science to Stop Drug Resistance in RET+ Lung Cancer

  Watanabe, H.

  30/04/24

  1 item of Media coverage

  Press/Media

• The NKF to Honor Nephrologist and NYU Professor of Medicine Dr. David Charytan With the Distinguished J. Michael Lazarus Award

  Lazarus, M.

  26/04/24

  1 item of Media coverage

  Press/Media

• THE NKF TO HONOR NEPHROLOGIST AND NYU PROFESSOR OF MEDICINE DR. DAVID CHARYTAN WITH THE DISTINGUISHED J. MICHAEL LAZARUS AWARD

  Lazarus, M.

  24/04/24

  1 item of Media coverage

  Press/Media

• The NKF to Honor Nephrologist and NYU Professor of Medicine Dr. David Charytan with the Distinguished J. Michael Lazarus Award

  Lazarus, M.

  24/04/24

  1 item of Media coverage

  Press/Media